Trauma and Extremities — Net Sales
Stryker Trauma and Extremities — Net Sales decreased by 82.8% to $1.04B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 82.4%, from $5.87B to $1.04B. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates strong market adoption of the company's trauma surgical solutions and potential expansion in surgical procedure volumes, while a decrease may signal competitive pressure or a slowdown in elective and trauma-related orthopedic surgeries.
Detailed definition
This metric represents the total revenue generated from the sale of medical devices and implants specifically designed f...
Peer comparison
Peers in the medical device sector report similar revenue streams under orthopedic or trauma-specific segments, often benchmarked against total orthopedic market growth rates.
syk_segment_trauma_and_extremities_net_salesHistorical Data
| Q2 '21 | Q2 '21 | Q3 '21 | Q3 '21 | Q4 '21 | Q4 '21 | Q1 '22 | Q1 '22 | Q2 '22 | Q2 '22 | Q3 '22 | Q3 '22 | Q4 '22 | Q4 '22 | Q1 '23 | Q1 '23 | Q2 '23 | Q2 '23 | Q3 '23 | Q3 '23 | Q4 '23 | Q4 '23 | Q1 '24 | Q1 '24 | Q2 '24 | Q2 '24 | Q3 '24 | Q3 '24 | Q4 '24 | Q4 '24 | Q1 '25 | Q1 '25 | Q2 '25 | Q2 '25 | Q3 '25 | Q3 '25 | Q4 '25 | Q4 '25 | Q1 '26 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.29B | $674M | $4.16B | $639M | $4.7B | $711M | $4.28B | $685M | $4.49B | $676M | $4.48B | $672M | $5.2B | $774M | $4.78B | $769M | $5B | $766M | $4.91B | $752M | $5.82B | $860M | $5.24B | $830M | $5.42B | $832M | $5.49B | $849M | $6.44B | $996M | $5.87B | $945M | $6.02B | $957M | $6.06B | $960M | $7.17B | $1.09B | $6.02B | $1.04B |
| QoQ Change | — | -84.3% | +517.2% | -84.6% | +635.7% | -84.9% | +501.3% | -84.0% | +555.9% | -85.0% | +562.6% | -85.0% | +674.1% | -85.1% | +517.3% | -83.9% | +549.7% | -84.7% | +540.9% | -84.7% | +673.3% | -85.2% | +509.7% | -84.2% | +553.3% | -84.7% | +560.3% | -84.5% | +658.1% | -84.5% | +489.0% | -83.9% | +537.2% | -84.1% | +532.9% | -84.2% | +647.0% | -84.9% | +454.3% | -82.8% |
| YoY Change | — | — | — | — | — | — | — | — | +4.6% | -84.3% | +7.7% | -83.8% | +10.7% | -83.5% | +11.8% | -82.0% | +11.2% | -83.0% | +9.6% | -83.2% | +11.8% | -83.5% | +9.7% | -82.6% | +8.5% | -83.3% | +11.9% | -82.7% | +10.7% | -82.9% | +11.9% | -82.0% | +11.1% | -82.3% | +10.2% | -82.5% | +11.4% | -83.1% | +2.6% | -82.4% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Stryker's trauma and extremities — net sales?
- Stryker (SYK) reported trauma and extremities — net sales of $1.04B in Q1 2026.
- How has Stryker's trauma and extremities — net sales changed year-over-year?
- Stryker's trauma and extremities — net sales decreased by 82.4% year-over-year, from $5.87B to $1.04B.
- What does trauma and extremities — net sales mean?
- The total revenue earned from selling medical products used to treat bone fractures and extremity-related orthopedic injuries.